Generate Biomedicines, Inc. GENB Accrued Expenses And Other Liabilities Current
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept ck0002100782:AccruedExpensesAndOtherLiabilitiesCurrent.
The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Generate Biomedicines, Inc. 's accrued expenses and other liabilities current.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Generate Biomedicines, Inc. 's accrued expenses and other liabilities current?
- Generate Biomedicines, Inc. (GENB) reported accrued expenses and other liabilities current of $19.27M in Q1 2026.